| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
15,280,000 |
| Market
Cap: |
83.12(M) |
| Last
Volume: |
1,505,916 |
Avg
Vol: |
1,501,713 |
| 52
Week Range: |
$2.25 - $7.96 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.6 |
| Insider 6 Months : 14.8 |
| Insider 3/6 Months : 23.6 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Co.'s primary product candidate, the HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) (HEPZATO), is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In Europe, Co.'s commercial product is a stand-alone medical device having the same device components as the HEZPATO but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT® Hepatic Delivery System for Melphalan.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
53,764 |
357,764 |
382,819 |
561,734 |
| Total Buy Value |
$200,002 |
$981,272 |
$1,081,809 |
$1,756,761 |
| Total People Bought |
2 |
6 |
8 |
9 |
| Total Buy Transactions |
2 |
8 |
10 |
18 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Michel Gerard J |
See Remarks |
• • – |
2021-12-02 |
4 |
B |
$8.61 |
$199,752 |
D/D |
23,200 |
59,050 |
2.81 |
-19% |
|
| Rosalind Advisors, Inc. |
Director |
– • – |
2021-06-30 |
4 |
B |
$12.76 |
$70,180 |
I/I |
5,500 |
421,500 |
2.1 |
-7% |
|
| Salamon Steven A J |
Director |
– • – |
2021-06-30 |
4 |
B |
$12.76 |
$70,180 |
D/D |
5,500 |
419,500 |
2.39 |
-7% |
|
| Rosalind Advisors, Inc. |
Director |
– • – |
2021-06-28 |
4/A |
B |
$11.56 |
$57,800 |
I/I |
5,000 |
416,000 |
2.1 |
- |
|
| Salamon Steven A J |
Director |
– • – |
2021-06-28 |
4 |
B |
$11.56 |
$57,800 |
D/D |
5,000 |
414,000 |
2.39 |
-7% |
|
| Rosalind Advisors, Inc. |
Director |
– • – |
2021-06-28 |
4 |
B |
$11.56 |
$5,780,000 |
I/I |
500,000 |
416,000 |
2.1 |
-7% |
|
| Michel Gerard J |
Chief Executive Officer |
• • – |
2021-06-28 |
4 |
B |
$11.93 |
$74,563 |
D/D |
6,250 |
35,850 |
2.81 |
-7% |
|
| Michel Gerard J |
Chief Executive Officer |
• • – |
2021-06-25 |
4 |
B |
$11.35 |
$74,910 |
D/D |
6,600 |
29,600 |
2.81 |
-2% |
|
| Salamon Steven A J |
Director |
– • – |
2021-06-24 |
4 |
B |
$10.90 |
$49,050 |
D/D |
4,500 |
409,000 |
2.39 |
3% |
|
| Salamon Steven A J |
Director |
– • – |
2021-06-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(877,379) |
404,500 |
|
- |
|
| Rosalind Advisors, Inc. |
Director |
– • – |
2021-06-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(877,379) |
406,500 |
|
- |
|
| Aharon Gil |
Director |
– • – |
2021-06-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(877,379) |
402,000 |
|
- |
|
| Salamon Steven A J |
Director |
– • – |
2021-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
877,379 |
404,500 |
|
- |
|
| Rosalind Advisors, Inc. |
Director |
– • – |
2021-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
877,379 |
406,500 |
|
- |
|
| Aharon Gil |
Director |
– • – |
2021-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
877,379 |
402,000 |
|
- |
|
| Purpura John |
Chief Operating Officer |
• – – |
2021-05-13 |
4 |
B |
$9.42 |
$37,680 |
D/D |
4,000 |
18,713 |
2.74 |
-5% |
|
| Aharon Gil |
Director |
– • – |
2021-03-31 |
4 |
OE |
$10.00 |
$2,150,000 |
I/I |
215,000 |
402,000 |
|
- |
|
| Rosalind Advisors, Inc. |
Director |
– • – |
2021-03-31 |
4 |
OE |
$10.00 |
$2,150,000 |
I/I |
215,000 |
406,500 |
|
- |
|
| Salamon Steven A J |
Director |
– • – |
2021-03-31 |
4 |
A |
$10.00 |
$2,150,000 |
I/I |
215,000 |
404,500 |
|
- |
|
44 Records found
|
|
Page 2 of 2 |
|
|
0.04 (0.74%) 
